🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/09/2009 | 9,06 | 9,06 | 8,42 | 8,65 | +0,87% | 7,02% | 161.529 |
| 02/09/2009 | 8,68 | 8,87 | 8,53 | 8,57 | -1,29% | 3,88% | 253.167 |
| 01/09/2009 | 9,02 | 9,06 | 8,61 | 8,68 | -3,33% | 4,98% | 236.175 |
| 31/08/2009 | 9,32 | 9,32 | 8,65 | 8,98 | -1,23% | 7,23% | 471.522 |
| 28/08/2009 | 9,88 | 9,92 | 9,10 | 9,10 | -7,25% | 8,33% | 186.830 |
| 27/08/2009 | 9,92 | 9,96 | 9,66 | 9,81 | -1,13% | 3,02% | 86.642 |
| 26/08/2009 | 9,62 | 10,29 | 9,51 | 9,92 | +4,33% | 8,17% | 199.440 |
| 25/08/2009 | 9,77 | 9,77 | 9,47 | 9,51 | +0,00% | 3,07% | 243.389 |
| 24/08/2009 | 10,41 | 10,41 | 9,43 | 9,51 | -7,97% | 9,35% | 1.563.219 |
| 21/08/2009 | 10,44 | 10,67 | 10,26 | 10,33 | +0,00% | 3,94% | 167.540 |
| 20/08/2009 | 10,29 | 10,33 | 10,18 | 10,33 | +0,36% | 1,45% | 117.446 |
| 19/08/2009 | 10,37 | 10,44 | 10,26 | 10,29 | -1,79% | 1,80% | 100.134 |
| 18/08/2009 | 10,52 | 10,85 | 10,41 | 10,48 | +0,00% | 4,27% | 97.543 |
| 17/08/2009 | 10,67 | 10,82 | 10,41 | 10,48 | -3,45% | 3,86% | 100.855 |
| 14/08/2009 | 11,27 | 11,38 | 10,78 | 10,85 | -4,29% | 5,32% | 113.947 |
| 13/08/2009 | 11,79 | 11,94 | 11,19 | 11,34 | -3,81% | 6,35% | 93.669 |
| 12/08/2009 | 11,19 | 12,02 | 11,08 | 11,79 | +5,70% | 8,36% | 159.124 |
| 11/08/2009 | 11,15 | 11,38 | 11,04 | 11,15 | -0,33% | 3,02% | 136.469 |
| 10/08/2009 | 10,97 | 11,34 | 10,89 | 11,19 | +0,67% | 4,10% | 122.362 |
| 07/08/2009 | 10,93 | 11,15 | 10,74 | 11,12 | +3,85% | 3,77% | 95.298 |
| 06/08/2009 | 11,00 | 11,00 | 10,67 | 10,70 | -2,39% | 3,06% | 87.230 |
| 05/08/2009 | 11,12 | 11,12 | 10,70 | 10,97 | -1,01% | 3,70% | 86.615 |
| 04/08/2009 | 10,70 | 11,15 | 10,52 | 11,08 | -1,33% | 5,94% | 160.220 |
| 03/08/2009 | 10,74 | 11,23 | 10,67 | 11,23 | +6,01% | 5,23% | 239.194 |
| 31/07/2009 | 10,63 | 11,12 | 10,56 | 10,59 | -1,05% | 5,28% | 154.983 |
| 30/07/2009 | 11,12 | 11,23 | 10,59 | 10,70 | -2,39% | 5,72% | 136.255 |
| 29/07/2009 | 11,12 | 11,23 | 10,97 | 10,97 | -2,66% | 2,36% | 86.375 |
| 28/07/2009 | 11,15 | 11,38 | 11,04 | 11,27 | +0,33% | 3,02% | 68.902 |
| 27/07/2009 | 10,82 | 11,23 | 10,82 | 11,23 | +3,45% | 3,81% | 75.368 |
| 24/07/2009 | 11,04 | 11,04 | 10,56 | 10,85 | -2,69% | 4,41% | 145.232 |